DxS has launched a single-tube genotyping assay in its Scorpions fluorescent-detection technology line for the drug-metabolism gene UGT 1A1*28, the company said last week. The test can deliver results "within 30 minutes" and can be used with both real-time or end-point analysis, the company said.
ParAllele BioScience now offers 20,000 non-synonymous SNPs up from 10,000 as part of its human genotyping service, the company said last week. The latest SNP selection was obtained by genotyping "approximately 300" individuals from three ethnic populations, resulting in "more than 8 million" genotypes, the company said.
The Translational Genomics Research Institute has launched its MammaPrint gene-expression profile microarray diagnostic for breast cancer in the United States, the company said in a statement this week. The test "distinguishes between lymph node-negative breast cancer patients who would benefit from additional therapy from those who would not," the company said.